The annual Society for Neuroscience (SfN) conference is currently underway in Chicago. Thousands of neuroscientists have gathered here to discuss the latest topics in neuroscience research. They’re ...

The annual NEURAL Conference is the only regional graduate trainee neuroscience conference of its kind and the cornerstone of the efforts of the UAB Neuroscience Roadmap Scholars Program. The ...

May 2026 in Munich to co-create the EBRAINS 10-year Roadmap 2026–2036 — a shared vision and implementation plan for the next decade of digital neuroscience in Europe.

Featuring Keynote "Reuniting the Mind with the Heart" ATLANTA, Feb. 16, 2026 /PRNewswire/ -- The Atlanta Neuroscience Institute and Foundation proudly announce the 2026 World Neuroscience Day ...

The annual NEURAL Conference is the only regional graduate trainee neuroscience conference of its kind and the cornerstone of the efforts of the UAB Neuroscience Roadmap Scholars Program. The ...

WATERTOWN, Mass., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (VIGL) (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the ...

WATERTOWN, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for ...

WATERTOWN, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience (VIGL), Inc. , a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of ...

Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Alto’s ...